Replies to post #4034 on Seelos Therapeutics Inc (SEEL)

[shankapotamus]

$APRI, gaptastic: http://blog.chartmystock.com/2012/02/25/apri-gap-to-fill.aspx

[Dimitrios George]

Markkind,
I may be in the minority, but I think Vitaros will get to a slow start in Canada. It will be a new drug and it is my understanding that Canada does not allow commercial advertising of prescription drugs, much less the type of ads that Viagra/Cialis play here. Europe, if/when approved, will pick up faster. But I agree, even a small percentage of Vitaros sales allows the movement of other Nexact drugs that could spell fast and continuous growth for several years. Femprox approval, here or there, would be too good to be true, so I am not counting on it.